Personalized Immunotherapy: Therapeutic Cancer Vaccines

I have already written a lot about experimental immunotherapies. Previous posts have ranged from the strong signs of clinical activity already seen by anti-PD1 checkpoint therapies in MSI-high Colorectal Cancer (CRC), to an overview of why the more common non-MSI CRC has been resistant to immunotherapy intervention, and finally a…

Read Full Post

Reprogramming a Tumor for Death

In previous columns of The Currently Incurable Scientist, we’ve gone over a number of different types of colorectal cancer (CRC) experimental therapies – from targeted agents to various flavors of immunotherapies. In this installment, I want to introduce you to yet another area of intense…

Read Full Post

PROSPECT Trial – CRC Clinical Trial Update

Since the inception of Fight Colorectal Cancer (Fight CRC), we have advocated for and supported cancer research. Clinical trials are the cornerstone of much of our research focus. For this next installment in our clinical trials series, we catch up with Medical Advisory Board member, Dusty Deming,…

Read Full Post

Turning a Cold CRC Tumor Hot: Part 2

In part 1 we covered the differences between “hot” and “cold” tumors. To answer the question of what is being done to help CRC patients with non-MSI tumors (the majority of CRC patients), we’ll now discuss immunotherapy concepts for these patients. A Few Experimental Strategies…

Read Full Post

PACES Trial S0820 – CRC CLINICAL TRIAL UPDATE

Since the inception of Fight Colorectal Cancer (Fight CRC), we have advocated for and supported cancer research. Today kicks off the first off many blogs where I will update you on the latest clinical trials for colorectal cancer research. Learn the process of clinical trials. NCI’s…

Read Full Post

Ramucirumab – A New Treatment Option

The FDA approved the use of the drug ramucirumab (brand name Cyramza®) on April 24, 2015 for patients with metastatic colorectal cancer in combination with FOLFIRI. Ramucirumab with FOLFIRI is now approved for patients whose cancer has progressed during or after treatment with first line…

Read Full Post

Ramucirumab Treatment

There’s news coming out of a recent clinical trial evaluating the chemotherapy drug ramucirumab (Cyramza™) and colorectal cancer patients’ response. Read more to learn about this update in treatment. Breaking research for mCRC patients Recently Eli Lilly and Company announced that the RAISE trial showed…

Read Full Post

Another treatment option coming down the pike: TAS-102

Fight Colorectal Cancer stays actively involved in the research process from beginning to end. Part of our role in research is monitoring the progress of new drugs – drugs that may be used in treatment plans of colorectal cancer in the future. We actively work…

Read Full Post

Meet the One Million Strong – Diana Welch from Maryland

Be a part of One Million Strong and tell us how colorectal cancer has impacted your life! Share your story now!  MEET DIANA Diana Welch, Survivor Huntingtown, MD DIANA’S STORY After several months of severe upper abdominal pain and learning to be my own advocate, I…

Read Full Post
Page 1 of 212